Although discount playing cards may help ease the stress of large drug expenditures within the short term, they do not deal with the systemic concerns driving up prescription prices from the U.S. Broader plan adjustments could tackle the basis triggers of soaring drug rates, like lack of transparency in pricing along with the role of intermediaries